The Global cancer stem cells journal Market size is estimated to reach USD 2.98 Billion from USD 1.14 Billion in 2021, delivering a growth rate of 11% through 2030, according to a new report by Reports and Data. The demand for cancer stem cell markers is exponentially growing on account of growing public awareness regarding the therapeutic strength of products, public-private investments in drug development, and the development of a regulatory framework for cancer stem cell therapeutics.

The treatment of cancer can damage the hematopoietic stem cells in the body. The hematopoietic stem cells are stem cells that turn into blood cells. Stem cell transplant helps with blood-forming stem cells in patients that have undergone a high dosage of radiation or chemotherapy and have damaged stem cells as a reaction. Embryonic stem cells are the main source of stem cells for therapeutic purposes due to high potency and their indefinite lifespan. The growing prevalence of the deadly disease will supplement the market share over the forecast period. According to the World Health Organization, there were nearly 18.1 million new cancer cases and 9.6 million deaths in 2018. Cancer Research UK has predicted there will be 27.5 million new cases each year globally by 2040. 

The increasing morbidity and mortality rates of cancer have led to rising funding from the government along with growth in many research activities to develop stem cell therapies. Several industry players are supported by government funding for the development of these therapies. 

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3047

Some Key Factors Contributing to the Global Pharma Healthcare Market Growth

Unprecedented revenue growth of the global pharma healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in RD activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Further key findings from the report suggest:

• Based on treatment type, the autologous stem cell therapy segment is forecast to register the highest CAGR of 8.6% through 2030 on account of the low risk of complications associated with treatment. Additionally, the improved survival rate of patients, no requirement for the identification of an HLA-matched donor, affordability, and low risk of graft-versus-host diseases are some other factors bolstering segmental growth.
• Based on disease type, the lung cancer segment is estimated to account for the majority of the cancer stem cells journal market revenue share. According to the WHO, approximately 228.150 new cases of lung cancer were detected in 2019 in the U.S. alone, while 142,670 deaths occurred in the same year due to the disease. The rising trend of smoking cigarettes will foster market share over the forecast period.
• In terms of end-use, the hospital and surgical centers are estimated to account for 38.2% of the market revenue share through 2030.
• In the regional landscape, North America dominates the market share due to access to the latest advanced technologies, substantial investment by the public and private sectors, and strong economic growth. The availability of state-of-the-art research infrastructure, and rise in RD initiatives to develop therapeutic options for chronic diseases, will bolster regional market growth.
• Asia Pacific region is estimated to account for 25.2% of the market share by 2030 due to the highest prevalence of cancer, creating a huge demand for stem cell therapies in the region. 
• Europe is estimated to register a CAGR 11.2% through 2030 on account of supportive government initiatives and funding for stem cell RD activities in the region.
• In January 2020, LabCorp adopted the Ion Torrent Genexus System and Oncomine Precision Assay by Thermo Fisher Scientific for use in RD of companion diagnostics and other applications in oncology and precision medicine.

Top Players in the Global Cancer Stem Cell Market:

 AbbVie, Inc., Thermo Fisher Scientific, Inc., Bionomics, Merck KGaA, Miltenyi Biotec, LONZA, Stemline Therapeutics, Inc., Irvine Scientific, MacroGenics, Inc., and PromoCell GmbH, among others.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma healthcare industry revenue growth over the recent past.  

To know more about the report @ https://www.reportsanddata.com/report-detail/cancer-stem-cells-market

Cancer Stem Cell Market Segmentation:

Cancer Type Outlook (Revenue, USD Billion; 2019-2030)

• Chronic lymphocytic leukemia (CLL)
• Acute leukemia
• Aplastic anemia
• Osteopetrosis
• Others

Transplantation Outlook (Revenue, USD Billion; 2019-2030)

• Allogeneic stem cell therapy
• Autologous stem cell therapy

End-use Outlook (Revenue, USD Billion; 2019-2030)

• Hospitals and surgical laboratories
• Cell banks and tissue banks

• Pharmaceutical and biomedical companies
• Others

Global Cancer Stem Cell Market Report: Regional Segmentation

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3047

Read More Reports:

Trauma Devices Market: https://www.reportsanddata.com/report-detail/trauma-devices-market

Magnetic Resonance, Computed Tomography And Nuclear Medicine Imaging Market: https://www.reportsanddata.com/report-detail/magnetic-resonance-and-computed-tomography-and-nuclear-medicine-imaging-market

Minimally Invasive Surgical Instruments Market: https://www.reportsanddata.com/report-detail/minimally-invasive-surgical-instruments-market

Pigmentation Disorders Market: https://www.reportsanddata.com/report-detail/pigmentation-disorders-market

Xerosis Treatment Market: https://www.reportsanddata.com/report-detail/xerosis-treatment-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.